Wednesday, December 22, 2021

A Non Too Eloquent Treatment Dilemma

 To some degree the subject matter of this entry is speculative. Its inclusion seems warranted based on its implications for my fellow PCa Warriors. 

My primary anti-cancer agent Xtandi  appears to have my PCa well under control with a consistent PSA of .03 for the past several years. The dosage as prescribed by Dr. Myers is  four 140 mg capsules daily. While this protocol effectively controls the progression of my PCa, I am all but certain (1) it contributes to my chronic dizziness (2) precipitated a bone breaking fall about a year ago (3) currently retards (prevents?) my full recovery.

While I no longer need a wheelchair to navigate, I have not progressed beyond the use of a walker as my primary means of getting from point A to point B.. I do use a cane from time to time in an attempt to expedite the rehabilitation process. On rare occasions I waddle around without a navigational aid.
I have been rehabbing for roughly one year. It is my impression that most others who have had similar falls and broken bones return to independent navigation in a similar time frame. 
My current physician has indicated that had I been his patient from the outset my primary anti-cancer agent would be Lupron. My long time readers know I have been anti-Lupron from the outset. Herein lies the dilemma. Do I alter my protocol in an effort to expedite the recovery process or do I stay the course?
My perspective is: damned if I do and damned if I don't.
Stay tuned.